ABSTRACT

Objective:

Meconium stained amniotic fluid (MSAF) has been reported to be associated with an obstetric hazard and significantly increase risks of adverse neonatal outcomes at term, preterm and postterm neonates. We aimed to evaluate the neonates born through meconium stained amniotic fluid in this study.

Materials and Methods:

Delivery room data of the all liveborn neonates (n=2866) and clinical data of the meconium stained amniotic fluid neonates.

Results:

Ten percent of liveborn neonates were complicated by meconium stained amniotic fluid (n=288). Gestational age, birth weight, height, head circumference, female gender, active resuscitation, admission to the neonatal intensive care unit were statistically higher, and Apgar scores at 1 minute were lower in meconium stained neonates than the neonates born without meconium. Neonates born through meconium stained amniotic fluid were delivered from singleton pregnancies (p=0.007). Regression analysis showed that female sex and birth length were might affect the presence of meconium.

Conclusion:

This study results were shown that tracheal suctioning is not full prevent to meconium aspiration syndrome for who neonates born through MSAF. Meconium below to vocal cord was not present all MSAF neonates. Female gender and birth height may be related for neonates with born through MSAF.

Keywords:

Meconium stained amniotic fluid, meconium aspiration syndrome, neonate

INTRODUCTION

Meconium aspiration syndrome (MAS) is a life threatening respiratory disorder that occurs in 2% to 5% of neonates born through meconium stained amniotic fluid (MSAF) (1,2). Approximately 8-13% of all live births are complicated by MSAF (3,4). Routine intubation for tracheal suction in this setting is not suggested, because insufficient evidence to continue recommending this practice (Class IIb, LOE C-LD) according to 2015 new guideline (5,6).

In making this suggested change, greater value has been placed on harm avoidance over the unknown benefit of the intervention of routine tracheal intubation and suctioning. Therefore, emphasis should be made on starting ventilation within the first minute of life in non-breathing or ineffectively breathing infants. Appropriate intervention to support ventilation and oxygenation should be initiated as indicated for each individual infant. This may include intubation and suction if the airway is obstructed (7).

The objective of this study was to evaluate delivery room data including delivery room management and short-term outcomes of the liveborn neonates born through MSAF in a year in a tertiary care teaching hospital with a capacity of 26 level 3 beds in İstanbul, Turkey.

MATERIALS AND METHODS

In this intervention study, neonatal team (neonatologist and/or pediatrician with assistant pediatrics and neonatal nurse) was present in delivery room for attending every delivery.

Delivery room data of the all liveborn neonates [gender, birth weight (BW), birth lenght (BL), birth head circumference (HC), weeks of gestation (WG)], APGAR scores at 1 and 5 minutes after birth, mode of delivery, born through MSAF, need of active delivery room resuscitation and tracheal suctioning, meconium presence below the vocal cords, and clinical data of the meconium-stained neonates [admission to the neonatal intensive care unit (NICU)], diagnosis and severity of MAS, chest X-ray findings, need for mechanical ventilation, need for surfactant treatment, NICU stay and survival who were admitted to the NICU) prospectively recorded.

Hospital antepartum management protocol for MSAF is conventional therapy, and routine prophylactic amnioinfusion for the dilution of MSAF is not performed (7).

Our hospital postnatal delivery room management protocol of the meconium-stained neonates:

In 2010, this committee was published guidelines on newborn resuscitation: no recommendation is given to suction the upper airways at the perineum but it is recommended to inspect the oropharynx and trachea for obstruction and suction the lower airway before inflations are given when the infant is depressed as in 2005 (5,6).

Based on these protocols, hospital pediatric intervention in the meconium stained neonates depends on the infant is vigorous (5,6,9,10). Vigorous is respiratory efforts, good muscle tone and a heart rate more than 100 beats/min. When the neonate is not vigorous and depressed, intubation for tracheal suctioning is done without intrapartum suctioning.

NICU Criteria for diagnosis of MAS was accepted for born through MSAF; having an abnormal chest radiograph examined by a staff radiologist; and developing symptoms of respiratory distress within 12 hours of life that persists beyond 24 hours of life and requires oxygen (4). Severity criteria to define MAS proposed by Cleary and Wiswell (4,10): Incidence of MSAF and MAS were determined. Delivery room data of the neonates born through MSAF were compared with the neonates born without MSAF. Diagnosis and severity of MAS, chest X-ray findings, need for mechanical ventilation, need for bolus natural bovine surfactant treatment, NICU stay, and survival were evaluated. This study has been approved by the hospital local ethical committees.

NICU Criteria for diagnosis of MAS (4):

Severity criteria to define MAS proposed by Cleary and Wiswell (4,10):

Incidence of MSAF and MAS were determined. Delivery room data of the neonates born through MSAF were compared to the neonates born without MSAF. Diagnosis and severity of MAS, chest X-ray findings, need for mechanical ventilation, need for bolus natural bovine surfactant treatment (150 mg/kg/dose) (11), NICU stay, and survival were evaluated. This study has been approved by the hospital ethical committees.

Statistical Analysis

In this study, statistical analyses were performed using the NCSS (Number Cruncher Statistical System) 2007 Statistical Software (Utah, USA) package program, unpaired-t test and chi-square tests were used. Multiple logistic regression model was used to analyze the variables such as BW, BL, HC, WG. P-values <0.05 were considered to be statistically significant.

RESULTS

There were 2866 live born neonates from 1 January 2011 to 31 December 2011. Two hundred eighty eight liveborn neonates (10%) were complicated by MSAF, and 9.3% of them were diagnosed with MAS (27/288). Anthropometric data and Apgar scores at 1 minute and 5 minutes after birth were compared between the meconium-stained neonates and the neonates born without MSAF (Table 1). WG, BW, BL, HC were statistically higher, and the APGAR scores at 1 and 5 minutes after birth were statistically lower in the meconium-stained neonates (p<0.001). Comparison of the WG and BW between the meconium-stained neonates, and the neonates without MSAF is shown in Table 2. WG of the meconium-stained neonates was statistically higher than the neonates born without meconium (p=0.0001). Ninety point thirty percent of neonates born through MSAF was term neonates (37-42 completed WG) (n=260), 1.40% (n=4) was posterm neonates (>42 WG), 8.30% (n=24) was preterm neonates (<37 completed WG). Considering the incidence of MSAF according to gestational age, it was 80% (4/5) in posterm neonates, 5.8% (24/417) in preterm neonates, and 12% /260/2160) in term neonates. On the other hand, the distribution of the neonates according to the BW classification was not statistically different in the two groups (p>0.05). Delivery room features and admission to the NICU of the meconium-stained neonates and the neonates without MSAF were presented in Table 3. Females was statistically higher than males in the meconium stained neonates (p=0.04). The neonates born through MSAF were resuscitated 0.56 times higher than the neonates born without meconium (p=0.0001), and admitted to the NICU 0.45 times higher than the neonates born without meconium (p=0.0001). Tracheal suctioning was performed in 43 non-vigorous meconium-stained neonates (14.9%), and meconium below the vocal cords was present in 29 of them (67.44%). All the neonates born through MSAF were delivered from singleton pregnancies, and this finding was statistically significant (p=0.007). Female gender and BL indicated a significant association with neonates born through MSAF. Neonates born through MSAF have been found in female neonates 0.71 (0.55 to 0.91) times greater than male neonates. The odds of MSAF were 1.15 times greater in high length neonates [95% confidence interval (CI): 1.05, 1.27]. WG, HC and BW have not found to have a statistically significant effect on MSAF. Anthropometric data and delivery room features in non-vigorous meconium-stained neonates were compared according to diagnosis of MAS and summarised in Table 5. Gender, WG, BW, BL, HC, Apgar scores at 1 minute and 5 minutes after birth, and delivery mode were not significantly different between the two groups (p>0.05). On the other hand, meconium below the vocal cords was significantly higher in the neonates with MAS (21/22) than those without MAS (8/21) (p=0.0002).

Five meconium-stained neonates who did not received tracheal suctioning were admitted to the NICU after developing symptoms of respiratory distress in their first 12 hours of life, and considered as having MAS.

Six (13.95%) non-vigorous meconium stained neonates (3 of them with meconium below the vocal cords) were followed up in the level 1 basic care nursery after the immediate tracheal meconium suctioning and delivery room care. The rest of the non-vigorous meconium- stained neonates (n=15, 34.88%) were admitted to the NICU with a different diagnosis other than MAS (feeding intolerance and early neonatal sepsis) with normal chest X-ray findings. According to the severity criteria; severe, moderate, and mild MAS ratio were 18.5% (n=5), 29.6% (n=8), 51.85% (n=14), respectively (p>0.05). Chest X-ray findings were moderate to diffuse infiltration (n=13, 48%), minimal infiltration (n=7, 26%), and overinflation (n=7, 26%) in neonates with MAS. Three neonates were intubated and mechanically ventilated immediately after tracheal suctioning in the delivery room, and total 9 (33%) neonates needed mechanical ventilation, 3 (11%) neonates needed bolus surfactant replacement therapy, and none of them had persistent pulmonary hypertension in their echocardiographic examination performed by a single pediatric cardiologist. All the meconium-stained neonates admitted to the NICU were survived and their mean NICU stay was 12.95±11.42 days.

DISCUSSION

MAS is a common problem that most pediatricians will encounter in the delivery room and normal newborn nursery. The current thinking on prevention of MAS requires that depressed non-vigorous neonates be tracheally intubated and suctioned in the delivery room. Clearly, this approach will not prevent all cases but may attenuate the severity of MAS (4). Our prospective study showed that 10% of all live births were born through MSAF, and 9.3% of them was diagnosed with MAS. According to the studies previously reported, 7.9-20.4% live births were born through MSAF (2,3,12,13) and 2-11.3% were complicated by MAS (2,3,12,14,15). Our incidences of MSAF and MAS were similar to these above cited reports. In our study, meconium-stained neonates were observed as having higher anthropometric measures (BW, L, and HC), WG, and lower Apgar scores than the neonates born without meconium. In the study reported by Lee et al., WG, BW, and Apgar scores <7 were higher in meconium stained neonates. These results were similar to our results (16). However, we did not find any study comparing BL and HC between the neonates with and without meconium.

The frequency of MSAF was observed to increase with advanced WG in the present study. Meconium is uncommon before 36-38 WG (17). It is a common finding in amniotic fluid and placental specimens, particularly in term or post-term pregnancy (18). In post-term pregnancies the incidence varies from 28-52% (17). Gupta et al. reported the incidence of MSAF in post-term pregnancies as 55%, and in preterms as 7.8% (19). In a recent study published by Espinheira et al., posterm and term neonates with MAS were 22.2%, and 70.8%, respectively (17,19). In another study, Tybulewicz et al. reported that MSAF in preterm neonates born at <33 WG was 4.3% (20). In our study, the incidence of MSAF in post-term pregnancies was 80% whereas in preterms it was 5.8%. Among the 24 preterms, 21 (87.5%) were between 34-36 completed WG and the remaining 3 (12.5%) were <34 completed WG (28-33 weeks). Sedaghatian et al. showed that a BW of ≥4000 g is a risk factor for MSAF (21). However in our study, we could not observe a result supporting this finding. Females were observed in 54.9% of 288 neonates born through MSAF in our study and we found an association between female gender and MSAF. This finding was similar with the finding reported in the study of Balchin et al. (22). Lee et al., reported the higher risk of MSAF in term singleton gestation (16). Likewise, meconium-stained neonates were born only from singleton pregnancies in our study. In other words, twin pregnancy was not observed in the study period. Fischer et al. has reported similar finding in twin pregnancy related MSAF in their recent published study (23).

In the study of Lee et al., the association of nulliparity, increase of WG, Caesarean delivery, low Apgar score (<7 points), and increase of BW were found to be risk factors for MSAF (16). In our study, female gender and BL were found to be risk factors for MSAF. There was no significant difference in mode of delivery (including breech and vacuum extraction) between MSAF absent and MSAF present. Neonates born through MSAF needed more admission to the NICU (relative risk: 0.45, 95% CI: 0.34 to 0.61). Our NICU admission result is in accordance with the study of Lee et al. in their study, NICU admission of the neonates with MSAF was higher than the neonates without meconium (16). On the other hand, in our study we observed that they needed higher resuscitation immediately after birth than these neonates born without MSAF. According to the report of Hageman et al. in 1988 meconium below the vocal cords was present in 76% of the neonates born through MSAF, and 10% of these neonates developed MAS (24). In our study, meconium below the vocal cords was present in 67.44%, and 50% developed MAS.

The current thinking on prevention of MAS requires that depressed infants be tracheally intubated and suctioned in the delivery room (5,6,8,9). In our study, severe MAS was found 18.5% in the depressed neonates with the presence of meconium below the vocal cords. Also, 13.95% of the depressed neonates did not admitted to the NICU after the delivery room care. We observed that tracheal suctioning of meconium in depressed meconium stained neonates can prevent MAS and attenuate the clinical severity of MAS. In the other hand, some vigorous neonates born through MSAF (18.5%) can develop MAS as seen in our study.

Espinheira et al. reported in their study radiographic abnormalities were observe d in 63.9% newborns and 26.4% newborns presented normal chest radiography, and of the newborns with MAS 43.1% required ventilatory support and surfactant therapy was used in 8.3% newborns (17). Similar to this study, radiographic abnormalities such as diffuse, moderate, minimal infiltration, and overinflation were observed in all the neonates who diagnosed with MAS in our study. Of these neonates, 33% required ventilatory support, and 11% needed surfactant therapy.

Study Limitation

The limitation of this study is the absence of the comparison of the effect of our delivery room policy with any other mode of management.

CONCLUSION

As a conclusion, when to do tracheal suction and how to do it well for MSAF neonates are still a hot topic. Every step in perinatal and postnatal care affects their outcomes. Tracheal suctioning after birth seems to be an optimal perinatal management strategy to the depressed meconium stained neonates. Further studies comparing different modes of management are needed.

References

Aguilar AM, Satragno DS, Vain NE, Szyld EG, Prudent LM. Delivery room practices in infants born through meconium stained amniotic fluid: a national survey. Arch Argent Pediatr 2010;108:31-9.

Whitfield JM, Charsha DS, Chiruvolu A. Prevention of meconium aspiration syndrome: an update and the Baylor experience. Proc (Bayl Univ Med Cent) 2009;22:128-31.

Liu WF, Harrington T. Delivery room risk factors for meconium aspiration syndrome. Am J Perinatol 2002;19:367-78.

Walsh MC, Fanaroff JM. Meconium stained fluid: approach to the mother and the baby. Clin Perinatol 2007;34:653-65.

Biban P, Filipovic-Grcic B, Biarent D, Manzoni P. International Liaison Committee on Resuscitation (ILCOR); European Resuscitation Council (ERC); American Heart Association (AHA); American Academy of Pediatrics (AAP). New cardiopulmonary resuscitation guidelines 2010: managing the newly born in delivery room. Early Hum Dev 2011;87:9-11.

Roehr CC, Hansmann G, Hoehn T, Bührer C. The 2010 Guidelines on Neonatal Resuscitation (AHA, ERC, ILCOR): Similarities and Differences-What Progress Has Been Made since 2005. Klin Padiatr 2011;223:299-307.

Wyckoff MH, Aziz K, Escobedo MB, Kapadia VS, Kattwinkel J, Perlman JM, et al. Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2015;132(18 Suppl 2):S543-60.

American Academy of Pediatrics and American Heart Association: Neonatal resuscitation textbook. 5th edition. Chicago: American Academy of Pediatrics and American Heart Association; 2005. p. 2-6.

American Heart Association. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric basic life support. Pediatrics 2006;117:989-1004.

Cleary GM, Wiswell TE. Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 1998;45:511-29.

El Shahed AI, Dargaville P, Ohlsson A, Soll RF. Surfactant for meconium aspiration syndrome in full term/near term infants. Cochrane Database Syst Rev 2007;(3):CD002054.

Bhutani VK. Developing a systems approach to prevent meconium aspiration syndrome: lessons learned from multinational studies. J Perinatol 2008;28:30-5.

David AN, Njokanma OF, Iroha E. Incidence of and factors associated with meconium staining of the amniotic fluid in a Nigerian University Teaching Hospital. J Obstet Gynaecol 2006;26:518-20.

Bhat RY, Rao A. Meconium-stained amniotic fluid and meconium aspiration syndrome: a prospective study. Ann Trop Paediatr 2008;28:199-203.

van Ierland Y, de Boer M, de Beaufort AJ. Meconium-stained amniotic fluid: discharge vigorous newborns. Arch Dis Child Fetal Neonatal Ed 2010;95:69-71.

Lee KA, Mi Lee S, Jin Yang H, Park CW, Mazaki-Tovi S, Hyun Yoon B, et al. The frequency of meconium-stained amniotic fluid increases as a function of the duration of labor. J Matern Fetal Neonatal Med 2011;24:880-5.

Espinheira MC, Grilo M, Rocha G, Guedes B, Guimarães H. Meconium aspiration syndrome - the experience of a tertiary center. Rev Port Pneumol 2011;17:71-6.

Yurdakök M. Meconium aspiration syndrome: do we know? Turk J Pediatr 2011;53:121-9.

Gupta V, Bhatia BD, Mishra OP. Meconium stained amniotic fluid: antenatal, intrapartum and neonatal attributes. Indian Pediatr 1996;33:293-7.

Tybulewicz AT, Clegg SK, Fonfé GJ, Stenson BJ. Preterm meconium staining of the amniotic fluid: associated findings and risk of adverse clinical outcome. Arch Dis Child Fetal Neonatal Ed 2004;89:328-30.

Sedaghatian MR, Othman L, Hossain MM, Vidyasagar D. Risk of meconium-stained amniotic fluid in different ethnic groups. J Perinatol 2000;20:257-61.

Balchin I, Whittaker JC, Lamont RF, Steer PJ: Maternal and fetal characteristics associated with meconium-stained amniotic fluid. Obstet Gynecol 2011;117:828-35.

Fischer C, Rybakowski C, Ferdynus C, Sagot P, Gouyon JB. A Population-Based Study of Meconium Aspiration Syndrome in Neonates Born between 37 and 43 Weeks of Gestation. Int J Pediatr 2012;2012:321545

Hageman JR, Conley M, Francis K, Stenske J, Wolf I, Santi V, et al. Delivery room management of meconium staining of the amniotic fluid and the development of meconium aspiration syndrome. J Perinatol 1988;8:127-31.

Evaluation of the Neonates Born Through Meconium Stained Amniotic Fluid: A Single-Center Experience